To provide the billion dollars Chinese middle and upper-class markets with premium healthcare services in the People's Republic of China.

To be a leading medical service provider in the PRC, delivering premium specialty-medical services, consultancy as well as hospital management services based on the U.S. medical standards.

To maximize shareholders' value & optimize liquidity through a public listing in the United States.